This one here on Bllomberg - https://www.bloomberg.com/news/articles/2022-05-04/cancer-drug-developers-trade-below-cash-with-no-respite-in-sight
Oncology seems to be the hardest hit out of all biotechs... Just our luck. Considering, I think RAC is doing particularly well as it stands though. Obviously still getting smashed, but not as bad as others. I don't think this will be a V recovery like covid, but a bit of a slog over the next 12-18 months.
Let's hope our fundamentals continue to get stronger and we're in a good position come negotiations.
RAC - Charts & Price Action, page-11732
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.89 |
Change
0.120(6.80%) |
Mkt cap ! $321.0M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.93 | $1.78 | $563.4K | 302.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 108 | $1.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 4926 | 1 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |